Drug intelligence / Profile preview

epigallocatechin gallate + copper

Development stage
Preclinical
Lead developer
Sichuan University
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Implant, Intravesical, Topical
01

Overview

Epigallocatechin gallate + copper (EGCG-Cu) is a metal-phenolic coordination complex (or metal-phenolic network) formed by the chelation of the green tea-derived polyphenol (-)-epigallocatechin gallate (EGCG) with copper ions (Cu2+). This nanomaterial combines the antioxidant, anti-inflammatory, and anti-apoptotic properties of EGCG with the catalytic, angiogenic, and antimicrobial activities of copper. EGCG-Cu has been investigated for various biomedical applications, including as a biomimetic coating for vascular and hemodialysis access stents to prevent in-stent restenosis and thrombosis by catalyzing the release of nitric oxide (NO) from endogenous donors. It is also being developed as a component of wound dressings and hydrogels to promote wound and burn healing, alleviate periodontitis, treat osteoarthritis, and enhance the efficacy of Bacillus Calmette-Guérin (BCG) immunotherapy in bladder cancer.

Other names
EGCG-CuEGCG-Cu complexEGCG-copper complexEGCG/CuEGCG/Cu complexcopper-epigallocatechin gallate complexepigallocatechin gallate-copper complexepigallocatechin-3-gallate-copper complexepigallocatechin3-gallate-copper complexepigallocatechin 3-gallate-copper complex
02

Targets

HK2 (Hexokinase Type II)PFK (Phosphofructokinase-1 liver type)RPSA (37/67 kDa laminin receptor)

Beyond the preview

Go deeper on epigallocatechin gallate + copper.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on epigallocatechin gallate + copper.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call